CM
CM Management’s Iovance Biotherapeutics IOVA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.2M | Buy |
700,000
+200,000
| +40% | +$344K | 1.1% | 32 |
|
2025
Q1 | $1.67M | Buy |
500,000
+200,000
| +67% | +$666K | 1.67% | 27 |
|
2024
Q4 | $2.22M | Buy |
300,000
+50,000
| +20% | +$370K | 1.98% | 21 |
|
2024
Q3 | $2.35M | Hold |
250,000
| – | – | 1.87% | 21 |
|
2024
Q2 | $2.01M | Hold |
250,000
| – | – | 1.84% | 22 |
|
2024
Q1 | $3.71M | Hold |
250,000
| – | – | 3.11% | 7 |
|
2023
Q4 | $2.03M | Buy |
250,000
+50,000
| +25% | +$407K | 1.63% | 22 |
|
2023
Q3 | $910K | Buy |
+200,000
| New | +$910K | 0.97% | 35 |
|